Digital droplet PCR and next-generation sequencing refine minimal residual disease monitoring in acute lymphoblastic leukemia. uri icon

Overview

publication date

  • May 3, 2019

Research

keywords

  • Antineoplastic Combined Chemotherapy Protocols
  • Biomarkers, Tumor
  • Hematopoietic Stem Cell Transplantation
  • High-Throughput Nucleotide Sequencing
  • Neoplasm, Residual
  • Polymerase Chain Reaction
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma

Identity

Scopus Document Identifier

  • 85065438504

Digital Object Identifier (DOI)

  • 10.1080/10428194.2019.1607325

PubMed ID

  • 31050551

Additional Document Info

volume

  • 60

issue

  • 11